A D-peptide ligand of neuropeptide Y receptor Y1 serves as nanocarrier traversing of the blood brain barrier and targets glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A D-peptide ligand of neuropeptide Y receptor Y1 serves as nanocarrier traversing of the blood brain barrier and targets glioma

Published:2022-06 Issue: Volume:44 Page:101465
ISSN:1748-0132
Container-title:Nano Today
language:en
Short-container-title:Nano Today

Author:

Li Yanying,Pan Yuanbo,Wang Yinjie,Jiang Zhenqi,Akakuru Ozioma U.,Li Mingli,Zhang Xianyun,Yuan Bo,Xing Jie,Luo Lijia,Larhammar Dan,Wu Aiguo,Li Juan

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Bioengineering,Biotechnology

Reference47 articles.

1. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases;Arvanitis;Nat. Rev. Cancer,2020

2. Establishment and dysfunction of the blood-brain Barrier;Zhao;Cell,2015

3. Development, maintenance and disruption of the blood-brain barrier;Obermeier;Nat. Med.,2013

4. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases;Furtado;Adv. Mater.,2018

5. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies;Xie;Biomaterials,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Illuminating the invisible: Advancing bio-imaging and diagnosis with modified near-infrared fluorescents;Applied Materials Today;2024-06

2. Peptide‐Functionalized Inorganic Oxide Nanomaterials for Solid Cancer Imaging and Therapy;Advanced Materials;2024-02-23

3. Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson’s disease;Nature Communications;2023-12-08

4. Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier;Expert Opinion on Drug Delivery;2023-08-10

5. D‐type neuropeptide decorated AIEgen/RENP hybrid nanoprobes with light‐driven ROS generation ability for NIR‐II fluorescence imaging‐guided through‐skull photodynamic therapy of gliomas;Aggregate;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3